1. Home
  2. MRUS vs SXT Comparison

MRUS vs SXT Comparison

Compare MRUS & SXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • SXT
  • Stock Information
  • Founded
  • MRUS 2003
  • SXT 1882
  • Country
  • MRUS Netherlands
  • SXT United States
  • Employees
  • MRUS N/A
  • SXT N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • SXT Major Chemicals
  • Sector
  • MRUS Health Care
  • SXT Industrials
  • Exchange
  • MRUS Nasdaq
  • SXT Nasdaq
  • Market Cap
  • MRUS 2.7B
  • SXT 2.9B
  • IPO Year
  • MRUS 2016
  • SXT N/A
  • Fundamental
  • Price
  • MRUS $56.07
  • SXT $94.46
  • Analyst Decision
  • MRUS Strong Buy
  • SXT Buy
  • Analyst Count
  • MRUS 15
  • SXT 1
  • Target Price
  • MRUS $88.87
  • SXT $93.00
  • AVG Volume (30 Days)
  • MRUS 1.6M
  • SXT 276.5K
  • Earning Date
  • MRUS 05-07-2025
  • SXT 07-25-2025
  • Dividend Yield
  • MRUS N/A
  • SXT 1.74%
  • EPS Growth
  • MRUS N/A
  • SXT 41.11
  • EPS
  • MRUS N/A
  • SXT 3.02
  • Revenue
  • MRUS $54,732,000.00
  • SXT $1,564,883,000.00
  • Revenue This Year
  • MRUS $39.00
  • SXT $4.80
  • Revenue Next Year
  • MRUS $7.48
  • SXT $5.15
  • P/E Ratio
  • MRUS N/A
  • SXT $31.30
  • Revenue Growth
  • MRUS 42.77
  • SXT 6.30
  • 52 Week Low
  • MRUS $33.19
  • SXT $66.15
  • 52 Week High
  • MRUS $61.28
  • SXT $98.27
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 66.86
  • SXT 64.06
  • Support Level
  • MRUS $49.46
  • SXT $93.29
  • Resistance Level
  • MRUS $56.74
  • SXT $95.73
  • Average True Range (ATR)
  • MRUS 3.37
  • SXT 1.93
  • MACD
  • MRUS 1.57
  • SXT -0.69
  • Stochastic Oscillator
  • MRUS 91.31
  • SXT 52.90

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.

Share on Social Networks: